Skip to content
Disclosery

Vida Ventures Advisors, LLC

Follow

13F filer, CIK 1831423, BOSTON, MA

Vida Ventures Advisors, LLC reported $29,373,266 across 2 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-03.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001172661-25-004558

Period
2025-09-30
Reported value
$29.4M
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001172661-25-004558, largest first. % of portfolio is the value over $29,373,266, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KYTXKYVERNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: not reported; 2024Q1: 4,523,924 shares; 2024Q2: 4,523,924 shares; 2024Q3: 4,523,924 shares; 2024Q4: 4,523,924 shares; 2025Q1: 4,523,924 shares; 2025Q2: 4,523,924 shares; 2025Q3: 4,523,924 shares 4,523,924$27.1M92.41%0Timeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: 1,798,163 shares; 2024Q1: 1,798,163 shares; 2024Q2: 1,798,163 shares; 2024Q3: 1,798,163 shares; 2024Q4: 1,798,163 shares; 2025Q1: 1,798,163 shares; 2025Q2: 1,798,163 shares; 2025Q3: 1,798,163 shares 1,798,163$2.23M7.59%0Timeline

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001172661-25-004558 base2025-11-03acceptance time not in the bulk data set